Newsroom - Page 10

The Institute for Clinical and Economic Review (ICER) has released a draft version of their scoping document that will compare the clinical effectiveness and value of 2 chimeric antigen receptor (CAR)-T cell treatments being reviewed by the FDA.
MimiVax announced that its immunotherapy vaccine SurVaxM, which is being tested in clinical trials for glioblastoma, has been designated an orphan drug by the FDA.
Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
Two clinical-community interventions—enhanced primary care and enhanced primary care with coaching—are capable of improving parent-reported outcomes and a child’s quality of life for childhood obesity.
The results of a phase 2 study that explored the effects of luspatercept in patients with lower-risk myelodysplastic syndromes (MDS) were presented at the 22nd Congress of the European Hematology Association by Acceleron Pharma Inc. The company is developing the drug with Celgene.
In the first of a series from the Digestive Health Physicians Association, Dr Lawrence R. Kosinski writes about Project Sonar, an innovative proposed Advanced APM that has cleared the first regulatory step. Project Sonar has saved thousands in hospitalization costs in pilot studies.
Researchers have highlighted physician education as a potential solution for the opioid epidemic, based on their findings that attending a top-ranked medical school is associated with writing far fewer opioid prescriptions.
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST